ME, F., H, K., RA, H., S, R., FWA, V., TJ, S., . . . Farkouh, M. E. (2004). Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), cardiovascular outcomes: Randomised controlled trial. Lancet, 364(9435), 675.
Chicago Style (17th ed.) CitationME, Farouh, et al. "Comparison of Lumiracoxib with Naproxen and Ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), Cardiovascular Outcomes: Randomised Controlled Trial." Lancet 364, no. 9435 (2004): 675.
MLA (9th ed.) CitationME, Farouh, et al. "Comparison of Lumiracoxib with Naproxen and Ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), Cardiovascular Outcomes: Randomised Controlled Trial." Lancet, vol. 364, no. 9435, 2004, p. 675.